KingAB, Minimal reduction in insulin dosage with pramlintide when pretreatment near-normal glycemia is established and square-wave meal bolus is used. Endocr Pract.2009;15 (3): 229–33.
2.
MarreroDGCreanJZhangBKellmeyerTGlosterMHerrmannKRubinRFinebergNKoltermanO.Effect of adjunctive pramlintide treatment on treatment satisfaction in patients with type 1 diabetes. Diabetes Care.2007;30 (2): 210–6.
3.
HuffmanDMcLeanGSeagroveM.Continuous subcutaneous pramlintide infusion therapy in patients with type 1 diabetes: Observations from a pilot study. Endocr Pract.2009;15 (7): 689–96.
